Teachers and Teaching MethodsCOLLINGE J.Elementary (The) School Journal. 1976, Vol 76, Num 5, pp 259-265Article

Human prion diseases and bovine spongiform encephalopathy (BSE)COLLINGE, J.Human molecular genetics (Print). 1997, Vol 6, Num 10, pp 1699-1705, issn 0964-6906Article

DIFFERENTIAL ACTIONS OF DIAZEPAM ON THE RELEASE OF (³H)-5-HYDROXYTRYPTAMINE FROM CORTICAL AND MIDBRAIN RAPHE SLICES IN THE RATCOLLINGE J; PYCOCK C.1982; EUROPEAN JOURNAL OF PHARMACOLOGY; ISSN 0014-2999; NLD; DA. 1982; VOL. 85; NO 1-5; PP. 9-14; BIBL. 22 REF.Article

THE EFFECTS OF THYROXINE AND PROPANOLOL ON THE METABOLIC RATE OF DEGUSCOLLINGE J; KERN MD.1979; COMP. BIOCHEM. PHYSIOL., C; GBR; DA. 1979; VOL. 64; NO 2; PP. 271-274; BIBL. 30 REF.Article

Auditing reduces accidents by eleminating unsafe practicesCOLLINGE, J. A.Oil & gas journal. 1992, Vol 90, Num 34, pp 38-41, issn 0030-1388Article

THE EFFECT OF VARYING PROTEIN QUALITY AND ENERGY INTAKE ON THE NITROGEN METABOLISM OF PARENTERALLY FED VERY LOW BIRTHWEIGHT (<16009) INFANTSDUFFY B; GUNN T; COLLINGE J et al.1981; PEDIATR. RES.; ISSN 0031-3998; USA; DA. 1981; VOL. 15; NO 7; PP. 1040-1044; BIBL. 43 REF.Article

Playing clue with prion diseaseROBERTS, G. W; COLLINGE, J.Laboratory investigation. 1991, Vol 65, Num 6, pp 607-609, issn 0023-6837Article

Post-exposure prophylaxis after accidental prion inoculationAGUZZI, A; COLLINGE, J.Lancet (British edition). 1997, Vol 350, Num 9090, pp 1519-1520, issn 0140-6736Article

EFFECTS OF FUROSEMIDE IN THE NEWBORN.WOO WCR; DUPONT C; COLLINGE J et al.1978; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1978; VOL. 23; NO 3; PP. 266-271; BIBL. 31 REF.Article

ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B)PARKINSON, N; INCE, P. G; SHAW, P. J et al.Neurology. 2006, Vol 67, Num 6, pp 1074-1077, issn 0028-3878, 4 p.Article

Examination of the human prion protein-like gene Doppel for genetic susceptibility to sporadic and variant Creutzfeldt-Jakob diseaseMEAD, S; BECK, J; DICKINSON, A et al.Neuroscience letters. 2000, Vol 290, Num 2, pp 117-120, issn 0304-3940Article

Reversible conversion of monomeric human prion protein between native and fibrilogenic conformationsJACKSON, G. S; HOSSZU, L. L. P; POWER, A et al.Science (Washington, D.C.). 1999, Vol 283, Num 5409, pp 1935-1937, issn 0036-8075Article

Chromosome 14 familial Alzheimer's disease : the clinical and neuropathological characteristics of a family with a leucine→serine (L250S) substitution at codon 250 of the presenilin 1 geneHARVEY, R. J; ELLISON, D; HARDY, J et al.Journal of neurology, neurosurgery and psychiatry. 1998, Vol 64, Num 1, pp 44-49, issn 0022-3050Article

Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene: Pedigree but not mutation specific age at onset provides evidence for a further genetic factorFOX, N. C; KENNEDY, A. M; ROSSOR, M. N et al.Brain. 1997, Vol 120, pp 491-501, issn 0006-8950, 3Article

Prion protein is necessary for normal synaptic functionCOLLINGE, J; WHITTINGTON, M. A; SIDLE, K. C. L et al.Nature (London). 1994, Vol 370, Num 6487, pp 295-297, issn 0028-0836Article

Inherited prion disease with 144 base pair gen insertion. I: Genealogical and molecular studiesPOULTER, M; BAKER, H. F; HARDY, J et al.Brain. 1992, Vol 115, pp 675-685, issn 0006-8950, 3Article

Family support system in newborn medicine: does it work? Follow-up study of infants at riskPERRAULT, C; COATES, A. L; COLLINGE, J et al.The Journal of pediatrics. 1986, Vol 108, Num 6, pp 1025-1030, issn 0022-3476Article

Review: Contribution of transgenic models to understanding human prion diseaseWADSWORTH, J. D. F; ASANTE, E. A; COLLINGE, J et al.Neuropathology and applied neurobiology (Print). 2010, Vol 36, Num 7, pp 576-597, issn 0305-1846, 22 p.Article

Regional brain metabolite abnormalities in inherited prion disease and asymptomatic gene carriers demonstrated in vivo by quantitative proton magnetic resonance spectroscopyWALDMAN, A. D; CORDERY, R. J; MACMANUS, D. G et al.Neuroradiology (Berlin. Print). 2006, Vol 48, Num 6, pp 428-433, issn 0028-3940, 6 p.Article

A presenilin 1 R278I mutation presenting with language impairmentGODBOLT, A. K; BECK, J. A; COLLINGE, J et al.Neurology. 2004, Vol 63, Num 9, pp 1702-1704, issn 0028-3878, 3 p.Article

Early onset familial Alzheimer's disease: Mutation frequency in 31 familiesJANSSEN, J. C; BECK, J. A; CAMPBELL, T. A et al.Neurology. 2003, Vol 60, Num 2, pp 235-239, issn 0028-3878, 5 p.Article

The molecular pathology of CJD: old and new variantsJACKSON, G. S; COLLINGE, J.MP. Molecular pathology. 2001, Vol 54, Num 6, pp 393-399, issn 1366-8714Article

Clinical characteristics of a chromosome 17-linked rapidly progressive familial frontotemporal dementiaBASUN, H; ALMKVIST, O; LANNFELT, L et al.Archives of neurology (Chicago). 1997, Vol 54, Num 5, pp 539-544, issn 0003-9942Article

Clinical features of early onset, familial Alzheimer's disease linked to chromosome 14MULLAN, M; BENNETT, C; COLLINGE, J et al.American journal of medical genetics. 1995, Vol 60, Num 1, pp 44-52, issn 0148-7299Article

Rescue of neurophysiological phenotype seen in PrP null mice by transgene encoding human prion proteinWHITTINGTON, M. A; SIDLE, K. C. L; GOWLAND, I et al.Nature genetics. 1995, Vol 9, Num 2, pp 197-201, issn 1061-4036Article